Of course, well need more evidence, but based on the evidence so far, it appears that LDN has the potential to treat a wide variety of conditions MCAS included
Many patients lose 1020% of their body weight while also improving: Blood sugar regulation Appetite control Blood pressure Overall metabolic health At Be Well Medical Group, we prescribe FDA-approved GLP-1 medications when appropriate and tailor treatment based on your goals, response, and tolerance
Amiodarone by contrast, gave more variable results, with the C max exceeding the transcriptomics PoDs at all timepoints (minimum BER of 0.004) but higher PoDs from the other readouts with BERs between 0.5 and 3.5 depending on timepoint and laboratory
Here's a clear, plain-English breakdown - what the brand states, what this publication can confirm from the official site, and what falls squarely into "verify this yourself" territory